Table of Contents

company-logo

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Armata Pharmaceuticals Dividend Announcement

• Armata Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Armata Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Armata Pharmaceuticals Dividend History

Armata Pharmaceuticals Dividend Yield

Armata Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Armata Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Armata Pharmaceuticals Financial Ratios

P/E ratio-2.00
PEG ratio-0.39
P/B ratio-1.63
ROE89.12%
Payout ratio0.00%
Current ratio0.19
Quick ratio0.19
Cash Ratio0.15

Armata Pharmaceuticals Dividend FAQ

Does Armata Pharmaceuticals stock pay dividends?
Armata Pharmaceuticals does not currently pay dividends to its shareholders.
Has Armata Pharmaceuticals ever paid a dividend?
No, Armata Pharmaceuticals has no a history of paying dividends to its shareholders. Armata Pharmaceuticals is not known for its dividend payments.
Why doesn't Armata Pharmaceuticals pay dividends?
There are several potential reasons why Armata Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Armata Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Armata Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Armata Pharmaceuticals a dividend aristocrat?
Armata Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Armata Pharmaceuticals a dividend king?
Armata Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Armata Pharmaceuticals a dividend stock?
No, Armata Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Armata Pharmaceuticals stocks?
To buy Armata Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Armata Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.